| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CF | Common stock, par value $0.01 per share | Options Exercise | $1.27M | +30.5K | +9.04% | $41.59 | 368K | 28 Feb 2022 | Direct | |
| transaction | CF | Common stock, par value $0.01 per share | Options Exercise | $1.69M | +44.4K | +12.08% | $38.02 | 412K | 28 Feb 2022 | Direct | |
| transaction | CF | Common stock, par value $0.01 per share | Options Exercise | $6.01M | +117K | +28.5% | $51.17 | 529K | 28 Feb 2022 | Direct | |
| transaction | CF | Common stock, par value $0.01 per share | Options Exercise | $9.34M | +150K | +28.35% | $62.25 | 679K | 28 Feb 2022 | Direct | |
| transaction | CF | Common stock, par value $0.01 per share | Options Exercise | $12.3M | +341K | +50.21% | $36.19 | 1.02M | 28 Feb 2022 | Direct | |
| transaction | CF | Common stock, par value $0.01 per share | Options Exercise | $12.8M | +415K | +40.68% | $30.95 | 1.44M | 28 Feb 2022 | Direct | |
| transaction | CF | Common stock, par value $0.01 per share | Sale | -$57.7M | -720K | -50.15% | $80.10 | 716K | 28 Feb 2022 | Direct | F1 |
| transaction | CF | Common stock, par value $0.01 per share | Sale | -$30.5M | -379K | -52.9% | $80.60 | 337K | 28 Feb 2022 | Direct | F2 |
| transaction | CF | Common stock, par value $0.01 per share | Sale | -$13.2M | -165K | -100% | $80.15 | 0 | 28 Feb 2022 | See Footnote | F3 |
| transaction | CF | Common stock, par value $0.01 per share | Award | $0 | +159K | +47.06% | $0.00 | 496K | 28 Feb 2022 | Direct | F4 |
| transaction | CF | Common stock, par value $0.01 per share | Tax liability | -$5.71M | -70.3K | -14.18% | $81.19 | 425K | 28 Feb 2022 | Direct | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CF | Employee Stock Option (right to buy) | Options Exercise | $0 | -30.5K | -100% | $0.00* | 0 | 28 Feb 2022 | Common Stock, par value $0.01 per share | 30.5K | $41.59 | Direct | F6 |
| transaction | CF | Employee Stock Option (right to buy) | Options Exercise | $0 | -44.4K | -100% | $0.00* | 0 | 28 Feb 2022 | Common Stock, par value $0.01 per share | 44.4K | $38.02 | Direct | F7 |
| transaction | CF | Employee Stock Option (right to buy) | Options Exercise | $0 | -117K | -100% | $0.00* | 0 | 28 Feb 2022 | Common Stock, par value $0.01 per share | 117K | $51.17 | Direct | F8 |
| transaction | CF | Employee Stock Option (right to buy) | Options Exercise | $0 | -150K | -100% | $0.00* | 0 | 28 Feb 2022 | Common Stock, par value $0.01 per share | 150K | $62.25 | Direct | F9 |
| transaction | CF | Employee Stock Option (right to buy) | Options Exercise | $0 | -341K | -100% | $0.00* | 0 | 28 Feb 2022 | Common Stock, par value $0.01 per share | 341K | $36.19 | Direct | F10 |
| transaction | CF | Employee Stock Option (right to buy) | Options Exercise | $0 | -415K | -100% | $0.00* | 0 | 28 Feb 2022 | Common Stock, par value $0.01 per share | 415K | $30.95 | Direct | F11 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.70 to $80.4975, inclusive. The reporting person undertakes to provide to CF Industries Holdings, Inc., any security holder of CF Industries Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within that range. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.50 to $80.97, inclusive. The reporting person undertakes to provide to CF Industries Holdings, Inc., any security holder of CF Industries Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within that range. |
| F3 | The shares are held in a revocable trust for which the reporting person's spouse is the sole trustee and sole beneficiary. |
| F4 | Reflects shares of common stock earned pursuant to a performance restricted stock unit (PRSU) award granted in 2019, as determined by the Compensation and Management Development Committee based on pre-established performance metrics for the three-year performance period ended December 31, 2021. |
| F5 | The reporting person surrendered shares of common stock to the company in order to fulfill tax withholding obligations upon the vesting of performance restricted stock units (PRSUs). |
| F6 | The options vested in three equal installments on August 10, 2013, 2014 and 2015 and expire on August 10, 2022. |
| F7 | The options vested in three equal installments on August 12, 2014, 2015 and 2016 and expire on August 12, 2023. |
| F8 | The options vested in three equal installments on March 3, 2015, 2016 and 2017 and expire on March 3, 2024. |
| F9 | The options vested in three equal installments on March 3, 2016, 2017 and 2018 and expire on March 3, 2025. |
| F10 | The options vested in three equal installments on March 3, 2017, 2018 and 2019 and expire on March 3, 2026. |
| F11 | The options vested in three equal installments on March 3, 2018, 2019 and 2020 and expire on March 3, 2027. |